An Unbiased Scientific Record Should Be Everyone's Agenda

1. DickersinK

1990

The existence of publication bias and risk factors for its occurrence.

JAMA

263

1385

1389

2. ChanAWHróbjartssonAHaahrMTGøtzschePCAltmanDG

2004

Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles.

JAMA

291

2457

2465

3. BekelmanJELiYGrossCP

2003

Scope and impact of financial conflicts of interest in biomedical research.

JAMA

289

454

465

4. The PLoS Medicine Editors

2008

Making sense of non-financial competing interests.

PLoS Med

5

e199

doi:10.1371/journal.pmed.0050199

5. DavidoffFDeAngelisCDDrazenJMNichollsMGHoeyJ

2001

Sponsorship, authorship, and accountability.

N Engl J Med

345

825

826

6. PoolR

2000

Material transfer agreements.

In: Finding the path: Issues of access to research resources. National Academy Press. Availablehttp://www.nap.edu/catalog.php?record_id=9629. Accessed 22 January 2009

7. DickersinK

2008

Reporting and other biases in studies of Neurontin for migraine, psychiatric/bipolar disorders, nociceptive pain, and neuropathic pain.

Available: http://dida.library.ucsf.edu/tid/oxx18r10. Accessed 22 January 2009

8. LandefeldCSSteinmanMA

2009

The Neurontin legacy: Marketing through misinformation and manipulation.

New Engl J Med

360

103

106

9. ArmstrongD

2006 May 15

How the New England Journal missed warning signs on Vioxx. The Wall Street Journal.

Available: http://online.wsj.com/article/SB114765430315252591.html. Accessed 22 January 2009

10. BombardierCLaineLReicinAShapiroDBurgos-VargasR

2000

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

N Engl J Med

343

1520

1528

11. SmithR

2005

Medical journals are an extension of the marketing arm of pharmaceutical companies.

PLoS Med

2

e138

doi:10.1371/journal.pmed.0020138

12. PLoS Medicine

2009

Open-access license.

Available: http://journals.plos.org/plosmedicine/license.php. Accessed 22 January 2009

13. PLoS Medicine

2009

Competing interests of the PLoS Medicine Editors.

Available: http://journals.plos.org/plosmedicine/editors_interests.php. Accessed 22 January 2009

14. ZimmersTASheldonJLubarskyDALópez-MuñozFWatermanL

2007

Lethal injection for execution: Chemical asphyxiation.

PLoS Med

4

e156

doi:10.1371/journal.pmed.0040156

15. The PLoS Medicine Editors

2007

Lethal injection is not humane.

PLoS Med

4

e171

doi:10.1371/journal.pmed.0040171

16. GøtzschePCKassirerJPWoolleyKLWagerEJacobsA

2009

What should be done to tackle ghostwriting in the medical literature.

PLoS Med

6

e1000023

doi:10.1371/journal.pmed.1000023

17. FlanaginACareyLAFontanarosaPBPhillipsSGPaceBP

1998

Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals.

JAMA

280

222

224

18. ChanAW

2008

Bias, spin, and misreporting: Time for full access to trial protocols and results.

PLoS Med

5

e230

doi:10.1371/journal.pmed.0050230

19. Consolidated Standards of Reporting Trials

2009

The CONSORT statement.

Available: http://www.consort-statement.org/. Accessed 22 January 2009

20. World Medical Association

2008

Declaration of Helsinki.

Available: http://www.wma.net/e/policy/b3.htm. Accessed 22 January 2009